Axicabtagene ciloleucel Interactions
There are 301 drugs known to interact with axicabtagene ciloleucel, along with 5 disease interactions. Of the total drug interactions, 67 are major, 210 are moderate, and 24 are minor.
- View all 301 medications that may interact with axicabtagene ciloleucel
- View axicabtagene ciloleucel disease interactions (5)
Most frequently checked interactions
View interaction reports for axicabtagene ciloleucel and the medicines listed below.
- Abraxane (paclitaxel protein-bound)
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adriamycin (doxorubicin)
- Afinitor Disperz (everolimus)
- Alimta (pemetrexed)
- Arava (leflunomide)
- Arcapta (indacaterol)
- Arimidex (anastrozole)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Barhemsys (amisulpride)
- Belsomra (suvorexant)
- Benemid (probenecid)
- Biktarvy (bictegravir / emtricitabine / tenofovir alafenamide)
- Bosulif (bosutinib)
- Buphenyl (sodium phenylbutyrate)
- BuSpar (buspirone)
- Cardizem LA (diltiazem)
- Cathflo Activase (alteplase)
- Cayston (aztreonam)
- Celebrex (celecoxib)
- Cerezyme (imiglucerase)
- Copaxone (glatiramer)
- Corlanor (ivabradine)
- Cosmegen (dactinomycin)
- Creon (pancrelipase)
- Xgeva (denosumab)
Axicabtagene ciloleucel disease interactions
There are 5 disease interactions with axicabtagene ciloleucel which include:
Report options
QR code containing a link to this page
More about axicabtagene ciloleucel
- axicabtagene ciloleucel consumer information
- Compare alternatives
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.